News | 27 July 2012
NEW YORK, July 26 (UPI) -- A case involving an agreement to keep a low-priced generic copy of a drug off the market may be headed for the U.S. Supreme Court, an anti-trust expert says. Eleanor M. Fox, a professor at the New York University law school, ...
Click on the link to read the full article at UPI.com
(This link will open in a new window)